1995
DOI: 10.1111/j.1464-5491.1995.tb00409.x
|View full text |Cite
|
Sign up to set email alerts
|

The Effect of the Timing and the Administration of Acarbose on Postprandial Hyperglycaemia

Abstract: To clarify the optimum timing for ingestion of acarbose, a 100 mg dose of this oral hypoglycaemic agent was administered 30 min before, at the beginning, and 15 min after ingestion of a test meal, and the effects of the drug on blood glucose rises were compared with increases observed after a control meal (no drug). Twenty-four patients with Type 2 diabetes were included in a randomized, open, cross-over study. The smallest increases in blood glucose (p < 0.001) occurred when acarbose was taken at the beginnin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
12
0
2

Year Published

1998
1998
2023
2023

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 33 publications
(23 citation statements)
references
References 17 publications
(2 reference statements)
1
12
0
2
Order By: Relevance
“…Attenuation of the postprandial insulin secretion is crucial in type 2 diabetic patients, because excess insulin secretion may lead to obesity. In this connection, administration of acarbose at 15 min after the start of a meal reduced postprandial increase of the serum insulin levels in type 2 diabetic patients [18]. Our corresponding (intake schedule 2) results for miglitol in healthy subjects was consistent with those reported in the literature.…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…Attenuation of the postprandial insulin secretion is crucial in type 2 diabetic patients, because excess insulin secretion may lead to obesity. In this connection, administration of acarbose at 15 min after the start of a meal reduced postprandial increase of the serum insulin levels in type 2 diabetic patients [18]. Our corresponding (intake schedule 2) results for miglitol in healthy subjects was consistent with those reported in the literature.…”
Section: Discussionsupporting
confidence: 91%
“…In this connection, Rosak et al reported that the maximum glucose-lowering effect of acarbose was obtained when the drug was administered at the start of a meal or within 15 min after the start of a meal in type 2 diabetic patients [18]. Asakura et al reported that acarbose was effective when administered within 30 min after the start of a meal in healthy subjects or subjects with IGT [19].…”
Section: Discussionmentioning
confidence: 99%
“…After a 30 min infusion, intact chlorogenic acid was found in the gastric vein and aorta, showing that it is quickly absorbed in the rat stomach. In addition, 5-CQAs and caffeic acid were also absorbed in the small intestine challenge, however, did not produce a similar effect but more closely resembled the inhibition of postprandial blood glucose by acarbose, the most widely investigated alphaglycosidase inhibitor (Rosak et al, 1995). While the mechanisms for these observations are unknown, it is conceivable that the effect of EDGCB depends on chlorogenic acid molecules reaching the upper small intestine at the same time as the intestinal contents.…”
Section: Discussionmentioning
confidence: 94%
“…Previously, the single administration of acarbose within 15 or 30 min after the start of a meal was shown to decrease plasma glucose levels in two separate studies [6,7]. Despite these findings, diabetic patients are usually advised to take aGIs just before a meal.…”
Section: Discussionmentioning
confidence: 99%